Finance

Beta
Lists
XUP:FRA
Genfit SA
€8.46
-0.35%
(-0.030) 1D
Jun 3, 8:04:28 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for XUP...
Open
€8.46
High
€8.46
Low
€8.46
Mkt. cap
428.32M
Avg. vol.
14.00
Volume
0.00
52-wk high
€9.34
52-wk low
€3.01
EPS
-€1.72
No. of employees
188
Open
€8.46
High
€8.46
Low
€8.46
Mkt. cap
428.32M
Avg. vol.
14.00
Volume
0.00
52-wk high
€9.34
52-wk low
€3.01
EPS
-€1.72
No. of employees
188
News stories
From sources across the web
About Genfit SA
CEO-
Employees188
FoundedSep 15, 1999
Headquarters-
SectorBiotechnology
Websitegenfit.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
17.77M
17.77M
14.95M
14.95M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
12.56M
12.56M
39.10M
39.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.18M
5.18M
5.34M
5.34M
Operating expense
17.74M
17.74M
41.80M
41.80M
Total operating expenses
17.74M
17.74M
41.80M
41.80M
Operating income
31.50K
31.50K
-26.85M
-26.85M
Other non operating income
-4.12M
-4.12M
-12.41M
-12.41M
EBT including unusual items
-5.05M
-5.05M
-38.20M
-38.20M
EBT excluding unusual items
-5.06M
-5.06M
-38.39M
-38.39M
Income tax expense
-73.00K
-73.00K
-192.50K
-192.50K
Effective tax rate
1.45%
1.45%
0.50%
0.50%
Other operating expenses
-4.00K
-4.00K
-2.64M
-2.64M
Net income
-4.98M
-4.98M
-38.01M
-38.01M
Net profit margin
-28.02%
-28.02%
-254.24%
-254.24%
Earnings per share
-
-
-
-
Interest and investment income
147.50K
147.50K
1.05M
1.05M
Interest expense
-576.50K
-576.50K
-23.50K
-23.50K
Net interest expenses
-429.00K
-429.00K
1.03M
1.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
477.50K
477.50K
-26.37M
-26.37M
Gain or loss from assets sale
-6.00K
-6.00K
31.50K
31.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer